These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26142433)

  • 1. Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection.
    Fonville JM; Fraaij PL; de Mutsert G; Wilks SH; van Beek R; Fouchier RA; Rimmelzwaan GF
    J Infect Dis; 2016 Jan; 213(1):31-8. PubMed ID: 26142433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018.
    Jorquera PA; Mishin VP; Chesnokov A; Nguyen HT; Mann B; Garten R; Barnes J; Hodges E; De La Cruz J; Xu X; Katz J; Wentworth DE; Gubareva LV
    Sci Rep; 2019 Feb; 9(1):2676. PubMed ID: 30804469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational framework for influenza antigenic cartography.
    Cai Z; Zhang T; Wan XF
    PLoS Comput Biol; 2010 Oct; 6(10):e1000949. PubMed ID: 20949097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation from arginine to lysine at the position 189 of hemagglutinin contributes to the antigenic drift in H3N2 swine influenza viruses.
    Ye J; Xu Y; Harris J; Sun H; Bowman AS; Cunningham F; Cardona C; Yoon KJ; Slemons RD; Wan XF
    Virology; 2013 Nov; 446(1-2):225-9. PubMed ID: 24074585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility.
    Gouma S; Kim K; Weirick ME; Gumina ME; Branche A; Topham DJ; Martin ET; Monto AS; Cobey S; Hensley SE
    Nat Commun; 2020 Sep; 11(1):4566. PubMed ID: 32917903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying influenza vaccine efficacy and antigenic distance.
    Gupta V; Earl DJ; Deem MW
    Vaccine; 2006 May; 24(18):3881-8. PubMed ID: 16460844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A joint matrix completion and filtering model for influenza serological data integration.
    Yuan XT; Zhang T; Wan XF
    PLoS One; 2013; 8(7):e69842. PubMed ID: 23936111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A benchmark dataset of protein antigens for antigenicity measurement.
    Qiu T; Qiu J; Yang Y; Zhang L; Mao T; Zhang X; Xu J; Cao Z
    Sci Data; 2020 Jul; 7(1):212. PubMed ID: 32632108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus.
    Wu Y; Cho M; Shore D; Song M; Choi J; Jiang T; Deng YQ; Bourgeois M; Almli L; Yang H; Chen LM; Shi Y; Qi J; Li A; Yi KS; Chang M; Bae JS; Lee H; Shin J; Stevens J; Hong S; Qin CF; Gao GF; Chang SJ; Donis RO
    Nat Commun; 2015 Jul; 6():7708. PubMed ID: 26196962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody.
    Xiong X; Corti D; Liu J; Pinna D; Foglierini M; Calder LJ; Martin SR; Lin YP; Walker PA; Collins PJ; Monne I; Suguitan AL; Santos C; Temperton NJ; Subbarao K; Lanzavecchia A; Gamblin SJ; Skehel JJ
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9430-5. PubMed ID: 26170284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: Virological and clinical findings.
    Pan M; Gao R; Lv Q; Huang S; Zhou Z; Yang L; Li X; Zhao X; Zou X; Tong W; Mao S; Zou S; Bo H; Zhu X; Liu L; Yuan H; Zhang M; Wang D; Li Z; Zhao W; Ma M; Li Y; Li T; Yang H; Xu J; Zhou L; Zhou X; Tang W; Song Y; Chen T; Bai T; Zhou J; Wang D; Wu G; Li D; Feng Z; Gao GF; Wang Y; He S; Shu Y
    J Infect; 2016 Jan; 72(1):52-9. PubMed ID: 26143617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
    Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
    Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites.
    Winarski KL; Thornburg NJ; Yu Y; Sapparapu G; Crowe JE; Spiller BW
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9346-51. PubMed ID: 26170302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.
    Pushko P; Pujanauski LM; Sun X; Pearce M; Hidajat R; Kort T; Schwartzman LM; Tretyakova I; Chunqing L; Taubenberger JK; Tumpey TM
    Vaccine; 2015 Sep; 33(38):4975-82. PubMed ID: 26207590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of amino acid substitutions in H5 hemagglutinin of influenza A escape mutants.
    Kaverin NV; Rudneva IA; Timofeeva TA; Ignatieva AV; Shilov AA; Bovin NV; Ilyushina NA
    Virus Res; 2015 Dec; 210():81-9. PubMed ID: 26220479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites.
    An Y; McCullers JA; Alymova I; Parsons LM; Cipollo JF
    J Proteome Res; 2015 Sep; 14(9):3957-69. PubMed ID: 26202417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype.
    Mallajosyula VV; Citron M; Ferrara F; Temperton NJ; Liang X; Flynn JA; Varadarajan R
    Front Immunol; 2015; 6():329. PubMed ID: 26167164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families.
    Pinto AK; Williams GD; Szretter KJ; White JP; Proença-Módena JL; Liu G; Olejnik J; Brien JD; Ebihara H; Mühlberger E; Amarasinghe G; Diamond MS; Boon AC
    J Virol; 2015 Sep; 89(18):9465-76. PubMed ID: 26157117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir inhibits influenza virus replication and transmission following ocular-only aerosol inoculation of ferrets.
    Belser JA; Maines TR; Creager HM; Katz JM; Tumpey TM
    Virology; 2015 Oct; 484():305-312. PubMed ID: 26142497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease.
    Benoit A; Beran J; Devaster JM; Esen M; Launay O; Leroux-Roels G; McElhaney JE; Oostvogels L; van Essen GA; Gaglani M; Jackson LA; Vesikari T; Legrand C; Tibaldi F; Innis BL; Dewé W
    Open Forum Infect Dis; 2015 Apr; 2(2):ofv067. PubMed ID: 26180823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.